Axonal degeneration in motor neuron disease

被引:121
作者
Fischer, Lindsey R.
Glass, Jonathan D.
机构
[1] Emory Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Med, Lab Med, Atlanta, GA 30322 USA
关键词
amyotrophic lateral sclerosis; axonal degeneration; neuromuscula junction; superoxide dismutase; oxidative stress;
D O I
10.1159/000107704
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Growing evidence from animal models and patients with amyotrophic lateral sclerosis (ALS) suggests that distal axonal degeneration begins very early in this disease, long before symptom onset and motor neuron death. The cause of axonal degeneration is unknown, and may involve local axonal damage, withdrawal of trophic support from a diseased cell body, or both. It is increasingly clear that axons are not passive extensions of their parent cell bodies, and may die by mechanisms independent of cell death. This is supported by studies in which protection of motor neurons in models of ALS did not significantly improve symptoms or prolong lifespan, likely due to a failure to protect axons. Here, we will review the evidence for early axonal degeneration in ALS, and discuss possible mechanisms by which it might occur, with a focus on oxidative stress. We contend that axonal degeneration may be a primary feature in the pathogenesis of motor neuron disease, and that preventing axonal degeneration represents an important therapeutic target that deserves increased attention. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:431 / 442
页数:12
相关论文
共 138 条
  • [1] The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomy
    Adalbert, Robert
    Nogradi, Antal
    Szabo, Andras
    Coleman, Michael P.
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 24 (08) : 2163 - 2168
  • [2] Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2
    Adamec, E
    Mohan, P
    Vonsattel, JP
    Nixon, RA
    [J]. ACTA NEUROPATHOLOGICA, 2002, 104 (01) : 92 - 104
  • [3] Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation
    Aggarwal, A
    Nicholson, G
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (02) : 199 - 201
  • [4] Evolution of motor and sensory deficits in amyotrophic lateral sclerosis estimated by neurophysiological techniques
    Al Theys, P
    Peeters, E
    Robberecht, W
    [J]. JOURNAL OF NEUROLOGY, 1999, 246 (06) : 438 - 442
  • [5] Type I spinal muscular atrophy can mimic sensory-motor axonal neuropathy
    Anagnostou, E
    Miller, SP
    Guiot, MC
    Karpati, G
    Simard, L
    Dilenge, ME
    Shevell, MI
    [J]. JOURNAL OF CHILD NEUROLOGY, 2005, 20 (02) : 147 - 150
  • [6] Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration
    Araki, T
    Sasaki, Y
    Milbrandt, J
    [J]. SCIENCE, 2004, 305 (5686) : 1010 - 1013
  • [7] Armon C, 1999, MUSCLE NERVE, V22, P1571, DOI 10.1002/(SICI)1097-4598(199911)22:11<1571::AID-MUS13>3.3.CO
  • [8] 2-S
  • [9] Mitochondria, oxidants, and aging
    Balaban, RS
    Nemoto, S
    Finkel, T
    [J]. CELL, 2005, 120 (04) : 483 - 495
  • [10] Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target
    Barber, Sian C.
    Mead, Richard J.
    Shaw, Pamela J.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2006, 1762 (11-12): : 1051 - 1067